References of "Scantamburlo, Gabrielle"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailNeuroplasticité, neurogenèse et dépression : Considérations cliniques
Constant, Eric; PITCHOT, William ULg; Floris, Michel et al

in Acta Psychiatrica Belgica (2009)

Detailed reference viewed: 13 (2 ULg)
See detailPsychoneuroimmunologie
Scantamburlo, Gabrielle ULg

Learning material (2009)

Detailed reference viewed: 51 (17 ULg)
Full Text
Peer Reviewed
See detailThe TaqI A DRD2 polymorphism in type II alcohol dependence: a marker of age at onset or of a familial disease?
Pinto, Emmanuel ULg; Reggers, Jean ULg; Gorwood, Philip et al

in Alcohol (2009), 43(4), 271-5

Cloninger's type II is a severe, early-onset, male-limited, and genetically influenced, impulsive form of alcoholism. Significant association has been reported between the A1 allele of the D2 dopamine ... [more ▼]

Cloninger's type II is a severe, early-onset, male-limited, and genetically influenced, impulsive form of alcoholism. Significant association has been reported between the A1 allele of the D2 dopamine receptor (DRD2) gene, substance misuse and personality traits of impulsivity and novelty seeking. We assessed the association between the TaqI A DRD2 gene polymorphism with Cloninger's typology and family history of alcohol abuse, which is thought to be more frequent in type II alcoholics. Fifty-one male alcohol-dependent patients were discriminated between type I and type II according to age at onset of alcohol-related problems and interviewed about family history of alcoholism. The associations between DRD2 (A1 or A2 alleles), family history, and typology were assessed by Pearson's chi-square test. Although typology was not associated with the studied polymorphism, a higher rate of general family history of alcohol abuse was still observed in type II patients (chi(2)(1)=4.53; P=.033). Furthermore, the A1 allele of the DRD2 was significantly associated with paternal history of alcoholism (chi(2)(1)=4.66; P=.031) and male, first-degree, collateral history of alcoholism (chi(2)(1)=4.40; P=.036). Age at onset of alcohol-related problems as main discriminator between type I and type II alcohol dependence does not seem to be associated by the TaqI A DRD2 polymorphism. However, the A1 allele of the DRD2 may be a marker of male familial alcoholism, which has been associated with type II alcohol dependence. [less ▲]

Detailed reference viewed: 63 (7 ULg)
Full Text
Peer Reviewed
See detailThe short allele of the serotonin transporter promoter polymorphism influences relapse in alcohol dependence.
Pinto, Emmanuel ULg; Reggers, Jean ULg; Gorwood, Philip et al

in Alcohol & Alcoholism (2008), 43

Detailed reference viewed: 29 (6 ULg)
Full Text
Peer Reviewed
See detailVasopressin-neurophysin and DST in major depression : Relationship with suicidal behavior.
Pitchot, William ULg; Scantamburlo, Gabrielle ULg; Pinto, Emmanuel ULg et al

in Journal of Psychiatric Research (2008), 42

The purpose of the present study was to assess if AVP-neurophysin is associated with hypercortisolemia and suicidal behaviour in depressed patients. The study included 28 patients subgrouped into suicide ... [more ▼]

The purpose of the present study was to assess if AVP-neurophysin is associated with hypercortisolemia and suicidal behaviour in depressed patients. The study included 28 patients subgrouped into suicide attempters (n=13) and nonattempters (n=15). We assessed basal AVP-neurophysins concentrations and post-dexamethasone (DST) cortisol levels. Concentrations of AVP-neurophysins did not differ between DST suppressors and nonsuppressors: 0.29+/-0.13ng/ml vs 0.36+/-0.21ng/ml, (F=1.1, df=1, 27, p=0.30). Suicide attempters did not differ from nonattempters for AVP-neurophysins levels. Our results fail to support a role of AVP in the early cortisol escape. [less ▲]

Detailed reference viewed: 125 (43 ULg)
Full Text
Peer Reviewed
See detailDopamine et dépression: le neurotransmetteur oublié.
Pitchot, William ULg; Scantamburlo, Gabrielle ULg; Ansseau, Marc ULg

in Revue Médicale de Liège (2008), 63

Detailed reference viewed: 77 (15 ULg)
Full Text
Peer Reviewed
See detailPeptides neurohypophysaires et dépression unipolaire: quel avenir?.
Scantamburlo, Gabrielle ULg; Pitchot, William ULg; Ansseau, Marc ULg et al

in Revue Médicale de Liège (2008), 63

Detailed reference viewed: 29 (3 ULg)
Full Text
Peer Reviewed
See detailNeurobiologie et pharmacothérapie du trouble obsessionnel-compulsif.
Ansseau, Marc ULg; Scantamburlo, Gabrielle ULg; Pinto, Emmanuel ULg et al

in Revue Médicale de Liège (2008), 63

Detailed reference viewed: 39 (4 ULg)
Full Text
Peer Reviewed
See detailPlasma oxytocin levels and anxiety in patients with major depression
Scantamburlo, Gabrielle ULg; Hansenne, Michel ULg; Fuchs, Sonia et al

in Psychoneuroendocrinology (2007), 32(4), 407-410

Cerebrospinal fluid and plasmatic levels of oxytocin (OT) have been found to change in mood disorders. In post-mortem studies, the numbers of OT-expressing neurons in the paraventricular nucleus have been ... [more ▼]

Cerebrospinal fluid and plasmatic levels of oxytocin (OT) have been found to change in mood disorders. In post-mortem studies, the numbers of OT-expressing neurons in the paraventricular nucleus have been reported to be increased. Moreover, OT is considered as an endogenous antistress hormone. It has also revealed antidepressive effects. OT may contribute to the dysregulation of the HPA system in major depression. The aim of the study was to assess a possible relationship between anxiety and plasma oxytocin (OT) Levels in depressive patients. Severity of depression was estimated with the Hamilton Depression Rating Scale and anxiety by using the Spielberger State-Anxiety Inventory. Results showed a significant negative correlation between oxytocin and the scored symptoms depression (r = -0.58, p = 0.003) and anxiety (r = -0.61, p = 0.005). (C) 2007 Elsevier Ltd. All rights reserved. [less ▲]

Detailed reference viewed: 205 (12 ULg)
Full Text
Peer Reviewed
See detailNeurophysins in mood disorders.
Scantamburlo, Gabrielle ULg; Ansseau, Marc ULg; Legros, Jean-Jacques ULg

in Neuropeptide Research Trends (2007)

Detailed reference viewed: 12 (1 ULg)
Peer Reviewed
See detailTestostérone et troubles de l'humeur
Scantamburlo, Gabrielle ULg

Conference (2007)

Detailed reference viewed: 19 (2 ULg)
See detailTroubles bipolaires: de la psychopathologie au traitement
Scantamburlo, Gabrielle ULg

Learning material (2007)

Detailed reference viewed: 50 (13 ULg)
See detailPsychoneuroendocrinologie et neurosciences
Scantamburlo, Gabrielle ULg

Learning material (2007)

Detailed reference viewed: 16 (1 ULg)
Full Text
Peer Reviewed
See detailSyndrome de discontinuation associé aux antidépresseurs.
Pitchot, William ULg; Scantamburlo, Gabrielle ULg; Pinto, Emmanuel ULg et al

in Revue Médicale de Liège (2007), 62

Detailed reference viewed: 84 (9 ULg)
Full Text
Peer Reviewed
See detailTherapeutic utilisations of vasopressin and oxytocin in mood disorders.
Scantamburlo, Gabrielle ULg; Pitchot, William ULg; Pinto, Emmanuel ULg et al

in Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (2007), 1

Detailed reference viewed: 76 (11 ULg)
Full Text
Peer Reviewed
See detailOXYTOCIN, VASOPRESSIN AND ANXIETY IN MAJOR DEPRESSION: AGO-ANTAGONIST NEUROHROMONES
Scantamburlo, Gabrielle ULg; Hansenne, Michel ULg; Fuchs, Sonia et al

in European Neuropsychopharmacology (2006), 16

Detailed reference viewed: 45 (1 ULg)
Full Text
Peer Reviewed
See detailPlasma oxytocin and anxiety in depressed patients
Scantamburlo, Gabrielle ULg; Fuchs, Sonia; Pitchot, William ULg et al

in European Neuropsychopharmacology (2005, October), 15(Suppl. 3), 430

Detailed reference viewed: 21 (2 ULg)